Exploring CAR-T Cell Therapy Side Effects: Mechanisms and Management Strategies

Chimeric antigen receptor (CAR) T cell therapy has revolutionized the treatment of malignancies, especially hematological tumors, but toxicities have tempered its success. The main impediments to the development of CAR-T cell therapies are the following: cytokine release syndrome (CRS), immune-effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yugu, Qin, Diyuan, Shou, Arthur Churchill, Liu, Yanbin, Wang, Yongsheng, Zhou, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573998/
https://www.ncbi.nlm.nih.gov/pubmed/37834768
http://dx.doi.org/10.3390/jcm12196124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573998/
https://www.ncbi.nlm.nih.gov/pubmed/37834768
http://dx.doi.org/10.3390/jcm12196124

Ejemplares similares